BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Staging
26 results:

  • 1. Current role of Nuclear Medicine in the diagnosis and therapy of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Georgakopoulos A
    Hell J Nucl Med; 2023; 26 Suppl():49-51. PubMed ID: 37658564
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Enhancing information on stage at diagnosis for childhood cancer in Africa.
    Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Proposed Modified staging System for Medullary Thyroid Cancer: A SEER Analysis With Multicenter Validation.
    Wang Z; Fan X; Zha X; Xu Y; Yin Z; Rixiati Y; Yu F
    Oncologist; 2024 Jan; 29(1):e59-e67. PubMed ID: 37311049
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma.
    Zhang X; Wakabayashi H; Hiromasa T; Kayano D; Kinuya S
    Semin Nucl Med; 2023 Jul; 53(4):503-516. PubMed ID: 36641337
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Role of 68 Ga-DOTA-ssa PET/CT in the Management and Prediction of Peptide Receptor Radionuclide Therapy Response for Patients With Neuroendocrine tumors : A Systematic Review and Meta-analysis.
    Lee ONY; Tan KV; Tripathi V; Yuan H; Chan WW; Chiu KWH
    Clin Nucl Med; 2022 Sep; 47(9):781-793. PubMed ID: 35485851
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. 18F-FDG PET/CT May Predict tumor Type and Risk Score in Gestational Trophoblastic Disease.
    Bezzi C; Monaco L; Ghezzo S; Mathoux G; Bergamini A; Zambella E; Fallanca F; Samanes Gajate AM; Presotto L; Sabetta G; Mangili G; Cioffi R; Bettinardi V; Gianolli L; Mapelli P; Picchio M
    Clin Nucl Med; 2022 Jun; 47(6):525-531. PubMed ID: 35353763
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.
    Ambrosini V; Kunikowska J; Baudin E; Bodei L; Bouvier C; Capdevila J; Cremonesi M; de Herder WW; Dromain C; Falconi M; Fani M; Fanti S; Hicks RJ; Kabasakal L; Kaltsas G; Lewington V; Minozzi S; Cinquini M; Öberg K; Oyen WJG; O'Toole D; Pavel M; Ruszniewski P; Scarpa A; Strosberg J; Sundin A; Taïeb D; Virgolini I; Wild D; Herrmann K; Yao J
    Eur J Cancer; 2021 Mar; 146():56-73. PubMed ID: 33588146
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Novel Prognostic Models Predicting the Cancer-Specific Survival in Patients with Cutaneous Melanoma Based on Metastatic Lymph Node Status.
    Li W; Xu X; Zhang Y
    Ann Surg Oncol; 2021 Aug; 28(8):4572-4581. PubMed ID: 33432490
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine tumors: An ENETS Center of Excellence Experience.
    Malczewska A; Witkowska M; Wójcik-Giertuga M; Kuśnierz K; Bocian A; Walter A; Rydel M; Robek A; Pierzchała S; Malczewska M; Leś-Zielińska I; Czyżewski D; Ziora D; Pilch-Kowalczyk J; Zajęcki W; Kos-Kudła B
    Neuroendocrinology; 2021; 111(4):304-319. PubMed ID: 32335553
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Somatostatin Analogues in the Treatment of Neuroendocrine tumors: Past, Present and Future.
    Stueven AK; Kayser A; Wetz C; Amthauer H; Wree A; Tacke F; Wiedenmann B; Roderburg C; Jann H
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234481
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Novel PET tracers: added value for endocrine disorders.
    Bergeret S; Charbit J; Ansquer C; Bera G; Chanson P; Lussey-Lepoutre C
    Endocrine; 2019 Apr; 64(1):14-30. PubMed ID: 30875057
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The Search for an Alternative to [
    Waldmann CM; Stuparu AD; van Dam RM; Slavik R
    Theranostics; 2019; 9(5):1336-1347. PubMed ID: 30867834
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Neuroendocrine Neoplasia within the german NET Registry].
    ; ;
    Z Gastroenterol; 2018 Oct; 56(10):1237-1246. PubMed ID: 30304748
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Clinical Significance of a Small Component of Choriocarcinoma in Testicular Mixed germ cell tumor (MGCT).
    Hassan O; Epstein JI
    Am J Surg Pathol; 2018 Aug; 42(8):1113-1120. PubMed ID: 29794869
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
    Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Nuclear Medicine Imaging of Neuroendocrine tumors.
    Brabander T; Kwekkeboom DJ; Feelders RA; Brouwers AH; Teunissen JJ
    Front Horm Res; 2015; 44():73-87. PubMed ID: 26303705
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (ssa) PET/CT imaging in neuroendocrine tumors and can define disease status.
    Bodei L; Kidd M; Modlin IM; Prasad V; Severi S; Ambrosini V; Kwekkeboom DJ; Krenning EP; Baum RP; Paganelli G; Drozdov I
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1341-52. PubMed ID: 25947577
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study.
    Corrie PG; Marshall A; Dunn JA; Middleton MR; Nathan PD; Gore M; Davidson N; Nicholson S; Kelly CG; Marples M; Danson SJ; Marshall E; Houston SJ; Board RE; Waterston AM; Nobes JP; Harries M; Kumar S; Young G; Lorigan P
    Lancet Oncol; 2014 May; 15(6):620-30. PubMed ID: 24745696
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Evaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumors.
    Denecke T; Baur AD; Ihm C; Steffen IG; Tischer E; Arsenic R; Pascher A; Wiedenmann B; Pavel M
    Eur J Radiol; 2013 Oct; 82(10):e550-5. PubMed ID: 23891296
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A critical review of melanoma pathology reports for patients referred to the Western Australian Melanoma Advisory Service.
    Monshizadeh L; Hanikeri M; Beer TW; Heenan PJ
    Pathology; 2012 Aug; 44(5):441-7. PubMed ID: 22772338
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.